Agilon Health Inc [NYSE: AGL] loss -0.86% on the last trading session, reaching $4.59 price per share at the time.
If compared to the average trading volume of 4.48M shares, AGL reached a trading volume of 2630201 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Agilon Health Inc [AGL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGL shares is $7.31 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGL stock is a recommendation set at 2.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Agilon Health Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 30, 2024. While these analysts kept the previous recommendation, Citigroup raised their target price to Neutral. The new note on the price target was released on April 22, 2024, representing the official price target for Agilon Health Inc stock. Previously, the target price had yet another raise to $5, while Barclays analysts kept a Underweight rating on AGL stock. On February 26, 2024, analysts decreased their price target for AGL shares from 12 to 6.50.
The Average True Range (ATR) for Agilon Health Inc is set at 0.41, with the Price to Sales ratio for AGL stock in the period of the last 12 months amounting to 0.35. The Price to Book ratio for the last quarter was 2.79, with the Price to Cash per share for the same quarter was set at 0.99.
Trading performance analysis for AGL stock
Agilon Health Inc [AGL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.53. With this latest performance, AGL shares dropped by -34.99% in over the last four-week period, additionally sinking by -28.39% over the last 6 months – not to mention a drop of -73.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGL stock in for the last two-week period is set at 28.38, with the RSI for the last a single of trading hit 21.47, and the three-weeks RSI is set at 33.60 for Agilon Health Inc [AGL]. The present Moving Average for the last 50 days of trading for this stock 6.26, while it was recorded at 4.74 for the last single week of trading, and 7.32 for the last 200 days.
Agilon Health Inc [AGL]: A deeper dive into fundamental analysis
Agilon Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.36 and a Current Ratio set at 1.36.
Agilon Health Inc [AGL]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Agilon Health Inc posted -0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.02. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AGL.
An analysis of Institutional ownership at Agilon Health Inc [AGL]
There are presently around $111.37%, or 113.40%% of AGL stock, in the hands of institutional investors. The top three institutional holders of AGL stocks are: CLAYTON, DUBILIER & RICE, LLC with ownership of 100.0 million shares, which is approximately 24.3149%. FMR LLC, holding 56.93 million shares of the stock with an approximate value of $$372.3 million in AGL stocks shares; and FMR LLC, currently with $$368.94 million in AGL stock with ownership which is approximately 13.7168%.
